• Je něco špatně v tomto záznamu ?

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis

M. Bloomfield, I. Zentsova, T. Milota, A. Sediva, Z. Parackova

. 2022 ; 13 (-) : 983977. [pub] 20220912

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033294

Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood. Beyond the well-recognized Th17 failure, linked to the STAT1/STAT3 dysbalance-driven abrogation of antifungal defense, only little is known about the consequences of augmented STAT1 signaling in other cells, including, interestingly, the innate immune cells. STAT1-mediated signaling was previously shown to be increased in STAT1 GOF CD14+ monocytes. Therefore, we hypothesized that monocytes might represent important co-orchestrators of antifungal defense failure, as well as various immunodysregulatory phenomena seen in patients with STAT1 GOF CMC, including autoimmunity. In this article, we demonstrate that human STAT1 GOF monocytes are characterized by proinflammatory phenotypes and a strong inflammatory skew of their secretory cytokine profile. Moreover, they exhibit diminished CD16 expression, and reduction of classical (CD14++C16-) and expansion of intermediate (CD14++16+) subpopulations. Amongst the functional aberrations, a selectively enhanced responsiveness to TLR7/8 stimulation, but not to other TLR ligands, was noted, which might represent a contributing mechanism in the pathogenesis of STAT1 GOF-associated autoimmunity. Importantly, some of these features extend to STAT1 GOF monocyte-derived dendritic cells and to STAT1 GOF peripheral myeloid dendritic cells, suggesting that the alterations observed in monocytes are, in fact, intrinsic due to STAT1 mutation, and not mere bystanders of chronic inflammatory environment. Lastly, we observe that the proinflammatory bias of STAT1 GOF monocytes may be ameliorated with JAK inhibition. Taken together, we show that monocytes likely play an active role in both the microbial susceptibility and autoimmunity in STAT1 GOF CMC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033294
003      
CZ-PrNML
005      
20230131151400.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2022.983977 $2 doi
035    __
$a (PubMed)36172362
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bloomfield, Marketa $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia $u Department of Paediatrics, Thomayer University Hospital, First Faculty of Medicine, Charles University, Prague, Czechia
245    10
$a Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis / $c M. Bloomfield, I. Zentsova, T. Milota, A. Sediva, Z. Parackova
520    9_
$a Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood. Beyond the well-recognized Th17 failure, linked to the STAT1/STAT3 dysbalance-driven abrogation of antifungal defense, only little is known about the consequences of augmented STAT1 signaling in other cells, including, interestingly, the innate immune cells. STAT1-mediated signaling was previously shown to be increased in STAT1 GOF CD14+ monocytes. Therefore, we hypothesized that monocytes might represent important co-orchestrators of antifungal defense failure, as well as various immunodysregulatory phenomena seen in patients with STAT1 GOF CMC, including autoimmunity. In this article, we demonstrate that human STAT1 GOF monocytes are characterized by proinflammatory phenotypes and a strong inflammatory skew of their secretory cytokine profile. Moreover, they exhibit diminished CD16 expression, and reduction of classical (CD14++C16-) and expansion of intermediate (CD14++16+) subpopulations. Amongst the functional aberrations, a selectively enhanced responsiveness to TLR7/8 stimulation, but not to other TLR ligands, was noted, which might represent a contributing mechanism in the pathogenesis of STAT1 GOF-associated autoimmunity. Importantly, some of these features extend to STAT1 GOF monocyte-derived dendritic cells and to STAT1 GOF peripheral myeloid dendritic cells, suggesting that the alterations observed in monocytes are, in fact, intrinsic due to STAT1 mutation, and not mere bystanders of chronic inflammatory environment. Lastly, we observe that the proinflammatory bias of STAT1 GOF monocytes may be ameliorated with JAK inhibition. Taken together, we show that monocytes likely play an active role in both the microbial susceptibility and autoimmunity in STAT1 GOF CMC.
650    _2
$a antifungální látky $7 D000935
650    12
$a kandidóza chronická mukokutánní $x genetika $7 D002178
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a aktivační mutace $7 D000073659
650    _2
$a lidé $7 D006801
650    _2
$a monocyty $x metabolismus $7 D009000
650    _2
$a transkripční faktor STAT1 $x genetika $x metabolismus $7 D050794
650    _2
$a toll-like receptor 7 $x metabolismus $7 D051199
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zentsova, Irena $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
700    1_
$a Milota, Tomas $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
700    1_
$a Sediva, Anna $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
700    1_
$a Parackova, Zuzana $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 983977
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36172362 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151356 $b ABA008
999    __
$a ok $b bmc $g 1891841 $s 1184629
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 13 $c - $d 983977 $e 20220912 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...